Annual Retained Earnings
-$122.90 M
-$20.95 M-20.55%
December 31, 2023
Summary
- As of February 7, 2025, KRBP annual retained earnings is -$122.90 million, with the most recent change of -$20.95 million (-20.55%) on December 31, 2023.
- During the last 3 years, KRBP annual retained earnings has fallen by -$81.27 million (-195.23%).
- KRBP annual retained earnings is now -557.21% below its all-time high of -$18.70 million, reached on December 31, 2018.
Performance
KRBP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$143.30 M
-$7.43 M-5.47%
September 30, 2024
Summary
- As of February 7, 2025, KRBP quarterly retained earnings is -$143.30 million, with the most recent change of -$7.43 million (-5.47%) on September 30, 2024.
- Over the past year, KRBP quarterly retained earnings has dropped by -$7.43 million (-5.47%).
- KRBP quarterly retained earnings is now -538.96% below its all-time high of -$22.43 million, reached on December 31, 2019.
Performance
KRBP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
KRBP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.6% | -5.5% |
| 3 y3 years | -195.2% | -25.7% |
| 5 y5 years | -557.2% | -25.7% |
KRBP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.8% | at low | -113.2% | at low |
| 5 y | 5-year | -448.0% | at low | -539.0% | at low |
| alltime | all time | -557.2% | at low | -539.0% | at low |
Kiromic BioPharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$143.30 M(+5.5%) |
| Jun 2024 | - | -$135.87 M(+5.3%) |
| Mar 2024 | - | -$129.04 M(+5.0%) |
| Dec 2023 | -$122.90 M(+20.5%) | -$122.90 M(+4.0%) |
| Sep 2023 | - | -$118.21 M(+3.7%) |
| Jun 2023 | - | -$114.01 M(+6.3%) |
| Mar 2023 | - | -$107.25 M(+5.2%) |
| Dec 2022 | -$101.95 M | -$101.95 M(+7.4%) |
| Sep 2022 | - | -$94.88 M(+14.3%) |
| Jun 2022 | - | -$83.02 M(+11.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$74.58 M(+11.0%) |
| Dec 2021 | -$67.22 M(+61.5%) | -$67.22 M(+18.8%) |
| Sep 2021 | - | -$56.58 M(+12.1%) |
| Jun 2021 | - | -$50.46 M(+10.9%) |
| Mar 2021 | - | -$45.48 M(+9.3%) |
| Dec 2020 | -$41.63 M(+85.6%) | -$41.63 M(+9.4%) |
| Sep 2020 | - | -$38.06 M(+6.8%) |
| Jun 2020 | - | -$35.65 M(+46.8%) |
| Mar 2020 | - | -$24.28 M(+8.3%) |
| Dec 2019 | -$22.43 M(+19.9%) | -$22.43 M |
| Dec 2018 | -$18.70 M | - |
FAQ
- What is Kiromic BioPharma annual retained earnings?
- What is the all time high annual retained earnings for Kiromic BioPharma?
- What is Kiromic BioPharma annual retained earnings year-on-year change?
- What is Kiromic BioPharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly retained earnings year-on-year change?
What is Kiromic BioPharma annual retained earnings?
The current annual retained earnings of KRBP is -$122.90 M
What is the all time high annual retained earnings for Kiromic BioPharma?
Kiromic BioPharma all-time high annual retained earnings is -$18.70 M
What is Kiromic BioPharma annual retained earnings year-on-year change?
Over the past year, KRBP annual retained earnings has changed by -$20.95 M (-20.55%)
What is Kiromic BioPharma quarterly retained earnings?
The current quarterly retained earnings of KRBP is -$143.30 M
What is the all time high quarterly retained earnings for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly retained earnings is -$22.43 M
What is Kiromic BioPharma quarterly retained earnings year-on-year change?
Over the past year, KRBP quarterly retained earnings has changed by -$7.43 M (-5.47%)